| 000 | 01225 a2200349 4500 | ||
|---|---|---|---|
| 005 | 20250513123834.0 | ||
| 264 | 0 | _c19970929 | |
| 008 | 199709s 0 0 eng d | ||
| 022 | _a0163-4356 | ||
| 024 | 7 |
_a10.1097/00007691-199708000-00002 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aJohnston, A | |
| 245 | 0 | 0 |
_aSimple bioequivalence criteria: are they relevant to critical dose drugs? Experience gained from cyclosporine. _h[electronic resource] |
| 260 |
_bTherapeutic drug monitoring _cAug 1997 |
||
| 300 |
_a375-81 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _aArea Under Curve |
| 650 | 0 | 4 | _aChemistry, Pharmaceutical |
| 650 | 0 | 4 | _aClinical Trials as Topic |
| 650 | 0 | 4 |
_aCyclosporine _xchemistry |
| 650 | 0 | 4 | _aFood-Drug Interactions |
| 650 | 0 | 4 | _aGuidelines as Topic |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aImmunosuppressive Agents _xchemistry |
| 650 | 0 | 4 | _aTherapeutic Equivalency |
| 650 | 0 | 4 | _aTime Factors |
| 650 | 0 | 4 | _aTransplantation |
| 700 | 1 | _aKeown, P A | |
| 700 | 1 | _aHolt, D W | |
| 773 | 0 |
_tTherapeutic drug monitoring _gvol. 19 _gno. 4 _gp. 375-81 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1097/00007691-199708000-00002 _zAvailable from publisher's website |
| 999 |
_c9242986 _d9242986 |
||